The proposal is aimed at clarifying the mechanism of lymphoreticular tumor development in patients undergoing immunosuppressive treatment. There is increasing evidence that cancer development in many organ systems is a multistep process, broadly divisible into initiation and promotion. Immunosuppressive agents currently in clinical use, such as cyclosporin A (CyA) are nono-genotoxic and, thus, are not likely to be an initiator of carcinogenesis, but rather they may act as a tumor promoter. In this proposal, we will first determine whether CyA and Azathioprine act as a promoter of induction of lymphoreticular neoplasms in experimental animals initiated with a subcarcinogenic dose of methylnitrosourea. In the preliminary study, we have demonstrated that the dietary administration of CyA induces atypical B cell proliferation in the lymphoid tissues of rats. Through our investigation on the mechanism of tumor promotion in the liver, we postulated that liver tumor promotion involves possible two components, a selective stimulation of the growth of initiated cells and a suppression of the surrounding non-initiated cells. The creation of differential growth environment will lead to amplification of the growth of initiated cell population. We will test this notion by demonstrating that immunosuppressants which act as a tumor promoter suppress the growth of subsets of lymphoid cells and selectively stimulate the proliferation of initiated cell populations leading to the development of lymphoreticular tumors. Whether or not the promoting potency of immunosuppressive agents correlates with their immunosuppressive effects on the hosts will be analyzed. We will further determine whether or not CyA and Azathioprine induce similar pathological lesions in the lymphoid tissue, and whether CyA-induced atypical lymphoid hyperplasia is reversible or progresses to neoplasia. The distinction of the stages of neoplastic development in lymphoma induction by immunosuppressive agents would be conceptually important, since the effects of promoters are reversible at least in the early stages, and the process may be amenable to modulations by selective therapeutic regimens.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA036175-03
Application #
3173678
Study Section
Pathology B Study Section (PTHB)
Project Start
1984-07-01
Project End
1987-06-30
Budget Start
1986-07-01
Budget End
1987-06-30
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Yabu, K; Warty, V S; Gorelik, E et al. (1991) Cyclosporine promotes the induction of thymic lymphomas in C57BL/6 mice initiated by a single dose of gamma-radiation. Carcinogenesis 12:43-6
Yabu, K; Warty, V S; Shinozuka, H (1991) Cyclosporine enhances the growth of carcinogen-induced enzyme-altered foci in rat liver. Hepatology 13:304-9
Shinozuka, H; Roebuck, B D; Longnecker, D S (1990) Cyclosporine inhibition of azaserine-induced atypical acinar cell foci in rat pancreas. Pancreas 5:389-93
Yokota, K; Gill 3rd, T J; Shinozuka, H (1989) Effects of oral versus topical administration of cyclosporine on phorbol ester promotion of murine epidermal carcinogenesis. Cancer Res 49:4586-90
Yokota, K; Hattori, A; Kunz, H W et al. (1989) Experimental analysis of the effects of cyclosporine on the induction and growth of epithelial tumors. Transplant Proc 21:3211-4
Shinozuka, H; Hattori, A; Gill 3rd, T J et al. (1988) Experimental models of malignancies after cyclosporine therapy. Transplant Proc 20:893-9
Hattori, A; Kunz, H W; Gill 3rd, T J et al. (1988) Diversity of the promoting action of cyclosporine on the induction of murine lymphoid tumors. Carcinogenesis 9:1091-4
Betschart, J M; Virji, M A; Shinozuka, H (1988) Cyclosporine A-induced alterations in rat hepatic glycogen metabolism. Transplant Proc 20:880-4
Hattori, A; Kunz, H W; Gill 3rd, T J et al. (1987) Thymic and lymphoid changes and serum immunoglobulin abnormalities in mice receiving cyclosporine. Am J Pathol 128:111-20
Perera, M I; Kunz, H W; Gill 3rd, T J et al. (1986) Enhancement of induction of intestinal adenocarcinomas by cyclosporine in rats given a single dose of N-methyl N-nitrosourea. Transplantation 42:297-302

Showing the most recent 10 out of 12 publications